Jason A. Lief, Partner, Windels Marx Lane & Mittendorf, LLP to Speak at The Knowledge Group’s Skinny-Labeling in Hatch-Waxman Litigations
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Jason A. Lief, Partner, Windels Marx Lane & Mittendorf, LLP will speak at its webcast entitled, “Skinny-Labeling in Hatch-Waxman Litigations: The Law in Flux?” This event is scheduled for Friday, March 31, 2023 from 12:00 pm to 1:00 pm (ET).
- (1888PressRelease) March 22, 2023 - For further details, please visit:
https://knowledgewebcasts.com/know-portfolio/skinny-labeling-in-hatch-waxman-litigations-cle/
About Jason A. Lief
Jason Lief is a premier patent trial lawyer with 25 years of experience. He has litigated and tried dozens of major patent and other intellectual property cases on behalf of some of the world’s most innovative and dynamic companies, often involving billion-dollar products. Applying his legal and scientific training, Jason has established a reputation for winning outcomes and courtroom excellence.
Jason’s cases include major Hatch-Waxman pharmaceutical litigations (Zantac®, Wellbutrin®, Wellbutrin SR®, Wellbutrin XL®, Ceftin®, Intuniv®, Vyvanse®, Oxtellar XR®, Angiomax®, and Lialda®), as well as biotech, chemical, and consumer product patent cases. Jason has also litigated trade secret, trademark, copyright, and IP contract disputes. He has argued before the U.S. Court of Appeals for the Federal Circuit and appeared in foreign courts pursuant to the Hague Convention. Jason has also successfully litigated in the inter partes review (IPR) arena.
About Windels Marx Lane & Mittendorf, LLP
Windels Marx is a full service, midsize law firm headquartered in New York, New York, with offices in New Brunswick and Madison, New Jersey, and Stamford, Connecticut. We have nearly 150 lawyers across more than 20 practice areas, the largest of which by volume of business are financial transactions, real estate, litigation, and bankruptcy. We serve a myriad of domestic and foreign clients, including banks and financial institutions, insurance companies, manufacturers, non-profit entities, and government sponsored enterprises. Industry benchmarking surveys routinely cite Windels Marx and its lawyers, including: Best Lawyers, Best Law Firms, City & State, Crain’s New York Business, New Jersey Law Journal, New York Law Journal, The Real Deal, ROI-NJ and Super Lawyers, among many others.
Event Summary:
A “skinny label” is a label on a generic pharmaceutical product that “carves out” (eliminates) the listing of an indication or disease for which the reference drug has been approved. Generic manufacturers use skinny labels to try to avoid “inducing” infringement of branded patents that claim the treatment of the carved-out diseases. But sometimes infringement can still be found. In what many see as a pivotal case – Glaxo v. Teva – the Federal Circuit found infringement despite a skinny label. The panelists will discuss the law of induced infringement before and after Glaxo v. Teva; what that case portends for the future; and what the U.S. Supreme Court may or may not do with the case.
I. The Law of Infringement by Inducement Generally
II. Inducement in the Context of Hatch-Waxman Cases – Pre-Glaxo v. Teva
III. Glaxo v. Teva at the District Court Case
IV. Glaxo v. Teva at the Federal Circuit
V. Supreme Court Petition for Certiorari
VI. Perspectives – Discussion
About The Knowledge Group
Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.
The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam